ATXS
Astria Therapeutics
ATXS
ATXS
Delisted
ATXS was delisted on the 22nd of January, 2026.
31 hedge funds and large institutions have $70.9M invested in Astria Therapeutics in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
31
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.51M | |
| 2 | +$1.1M | |
| 3 | +$866K | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$811K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$388K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$432K | |
| 3 | -$79K | |
| 4 |
D.E. Shaw & Co
New York
|
-$52K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$52K |